Amyotrophic Lateral Sclerosis (ALS) Market: Growth, Trends, and Key Insights 2025 | Top key players - Biogen Inc., Bausch Health, F Hoffmann-la Roche Ltd.

The latest report published by DataM Intelligence highlights the growth prospects of Amyotrophic Lateral Sclerosis (ALS) market. The industry expansion is majorly driven by developments in technology across the globe.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/amyotrophic-lateral-sclerosis-market?sz

The Global Amyotrophic Lateral Sclerosis Market size reached USD 0.7 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 1.0 billion by 2031. The global amyotrophic lateral sclerosis market is expected to exhibit a CAGR of 5.1% during the forecast period (2024-2031).

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurological condition that affects motor neurons, leading to muscle weakness, paralysis, and eventually loss of voluntary muscle control. The ALS market focuses on developing treatments to slow disease progression, manage symptoms, and improve patients' quality of life. Key players in this market are working on innovative therapies, diagnostics, and patient care solutions.

Competitive Evaluation:

Companies covered in this report are Sanofi S.A., Brainstorm Cell Therapeutics, Biogen Inc., Bausch Health, F Hoffmann-la Roche Ltd, Ionis Pharmaceuticals, Mylan Pharma, Sun Pharma, Orion Pharmaceuticals, and AB Science.

The Amyotrophic Lateral Sclerosis (ALS) Market analysis identifies a number of major market players. It enables companies to understand the strategies and partnerships used by other industry players to combat market competition. The comprehensive market report provides a fascinating microscopic look at the market. Corporations can detect the footprints of manufacturers by learning about demand, the global price of manufacturers, and the global benefit of manufacturing companies.

Key Development

On June 14, 2023, Coya Therapeutics, Inc., a clinical-stage biotechnology company focused on developing biologics to enhance Treg function, announced the appointment of Dr. Michelle Frazier, Ph.D., as Senior Vice President of Regulatory Affairs. Dr. Frazier, with her regulatory and CMC expertise, will guide and oversee all of Coya's regulatory submissions, including the upcoming IND submission for COYA 302, a treatment for Amyotrophic Lateral Sclerosis (ALS).

On May 17, 2023, PatientsLikeMe (PLM), a leading digital platform empowering over 850K patients to manage their health journeys, revealed a partnership with the Neurological Clinical Research Institute (NCRI) at Massachusetts General Hospital (MGH). The collaboration will share de-identified patient data to enhance research outcomes for ALS. Announced at the 2nd Annual ALS Drug Development Summit, this partnership allows international researchers access to a valuable dataset, which includes the Pooled Resource Open-Access ALS Clinical Trials (PRO-ACT) database with data from 29 clinical trials and 11,685 patient records. The data will be hosted and maintained by NCRI.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/amyotrophic-lateral-sclerosis-market

Amyotrophic Lateral Sclerosis (ALS) Market Segments

The report covers the segmentation of the market into different segments based on various classifications such as applications, end users, product types, and others. The segmentation is divided into two sections, one for development and the other for different roles, needs, and behaviors.

By Drug Type: Rilutek (Riluzole), Edaravone (Radicava), Others.

By Treatment Type: Physical therapy, Speech Therapy, Medication, Respiratory Therapy, Others.

By End-User: Diagnostic Centers, Hospitals, Clinics, Others.

Regional Assessment:

Regional analysis includes segmentation based on the geography that accentuates the recent and future demand for Amyotrophic Lateral Sclerosis (ALS) market across North America, Europe, Asia-Pacific, Middle East & Africa, and South America. The study also focuses on the demand for each application segment over all the prominent regions.

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

In terms of geographical analysis, Amyotrophic Lateral Sclerosis (ALS) Market report provides an in-depth view of:-

∎ Regional level break-up
∎ Leading growth rates
∎ Countries with the largest market share
∎ Market factors
∎ Latest developments
∎ Industry challenges
∎ Regulatory policies
∎ Player strategies

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/amyotrophic-lateral-sclerosis-market

This report provides a 360-degree synopsis of the competitive scenario of the Amyotrophic Lateral Sclerosis (ALS) industry. It has enormous awareness joined to the ongoing item and technical improvements in the business sector. It has a thorough analysis of the impact of the potential future development of these headways, a wide-ranging review of those extensions available for future growth.

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Browse More Reports: https://www.datamintelligence.com/research-report/amyotrophic-lateral-sclerosis-market

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.